37188660

Summary
Title
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy.
Authors
  • Kasiewicz LN
  • Biswas S
  • Beach A
  • Ren H
  • Dutta C
  • Mazzola AM
  • Rohde E
  • Chadwick A
  • Cheng C
  • Garcia SP
  • Iyer S
  • Matsumoto Y
  • Khera AV
  • Musunuru K
  • Kathiresan S
  • Malyala P
  • Rajeev KG
  • Bellinger AM
Source
Nat Commun
Publication Date
2023 May 15
PubMed ID
37188660

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024